Grace Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Grace Therapeutics, Inc. (GRCE) reported Foreign Currency Transaction Gain (Loss), Unrealized of $0 for the 12-month period ending 2024-03-31, per its 10-K filed 2024-06-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2024-06-21
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2024-03-31 was $0.00.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-12-31 was $0.00.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2024 was $0.00.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$5.00K, a 101.35% decline from fiscal 2022.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2022 was $370.00K.
- Grace Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2021 was -$814.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | $0.00 derived: sum of 2 quarters · filed 2024-06-21 | $0.00 derived: sum of 3 quarters · filed 2024-06-21 | $0.00 10-K · filed 2024-06-21 | |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $0.00 derived: sum of 2 quarters · filed 2024-02-12 | $0.00 10-Q · filed 2024-02-12 | -$33.00K derived: sum of 4 quarters · filed 2024-06-21 | |
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | -$33.00K derived: sum of 3 quarters · filed 2024-06-21 | -$56.00K derived: sum of 4 quarters · filed 2024-06-21 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | -$33.00K derived: sum of 2 quarters · filed 2024-06-21 | -$56.00K derived: sum of 3 quarters · filed 2024-06-21 | -$15.00K derived: sum of 4 quarters · filed 2024-06-21 | |
| 2023-03-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-21 | -$56.00K derived: sum of 2 quarters · filed 2024-06-21 | -$15.00K derived: sum of 3 quarters · filed 2024-06-21 | -$5.00K 10-K · filed 2024-06-21 | |
| 2022-12-31 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $18.00K derived: sum of 2 quarters · filed 2024-02-12 | $28.00K 10-Q · filed 2024-02-12 | -$20.00K derived: sum of 4 quarters · filed 2024-02-12 | |
| 2022-09-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $51.00K 10-Q · filed 2023-11-13 | $3.00K derived: sum of 3 quarters · filed 2023-11-13 | $1.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $10.00K 10-Q · filed 2023-08-11 | -$38.00K derived: sum of 2 quarters · filed 2023-08-11 | -$40.00K derived: sum of 3 quarters · filed 2023-08-11 | $1.12M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | -$50.00K derived: sum of 2 quarters · filed 2023-06-23 | $1.11M derived: sum of 3 quarters · filed 2023-06-23 | $370.00K 10-K · filed 2023-06-23 | |
| 2021-12-31 | -$2.00K 10-Q · filed 2022-02-14 | $1.16M derived: sum of 2 quarters · filed 2022-02-14 | $418.00K 10-Q · filed 2023-02-14 | -$602.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-09-30 | $1.16M 10-Q · filed 2021-11-10 | -$420.00K 10-Q · filed 2022-11-14 | $420.00K 10-Q · filed 2021-11-10 | -$600.00K derived: sum of 3 quarters · filed 2022-08-11 | -$546.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-06-30 | -$740.00K 10-Q · filed 2022-08-11 | -$1.76M derived: sum of 2 quarters · filed 2022-08-11 | -$1.71M derived: sum of 3 quarters · filed 2022-08-11 | -$1.69M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-21 | -$968.00K derived: sum of 2 quarters · filed 2022-06-21 | -$948.00K derived: sum of 3 quarters · filed 2022-06-21 | -$814.00K 10-K · filed 2022-06-21 | |
| 2020-12-31 | $54.00K 10-Q · filed 2022-02-14 | $74.00K derived: sum of 2 quarters · filed 2022-02-14 | $208.00K 10-Q · filed 2022-02-14 | -$38.00K derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | $20.00K 10-Q · filed 2021-11-10 | $154.00K 10-Q · filed 2021-11-10 | -$92.00K derived: sum of 3 quarters · filed 2021-11-10 | $10.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $134.00K 10-Q · filed 2021-08-12 | -$112.00K derived: sum of 2 quarters · filed 2021-08-12 | -$10.00K derived: sum of 3 quarters · filed 2021-08-12 | -$74.00K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$246.00K 10-K · filed 2020-06-29 | -$144.00K derived: sum of 2 quarters · filed 2021-02-09 | -$208.00K derived: sum of 3 quarters · filed 2021-02-09 | -$246.00K 10-K · filed 2021-06-22 | |
| 2019-12-31 | $102.00K 10-Q · filed 2021-02-09 | $38.00K derived: sum of 2 quarters · filed 2021-02-09 | $151.00K 10-Q · filed 2021-02-09 | -$282.00K derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-09-30 | -$64.00K 10-Q · filed 2020-11-16 | $45.00K 10-Q · filed 2020-11-16 | -$384.00K derived: sum of 3 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $60.00K 10-Q · filed 2020-08-13 | -$320.00K derived: sum of 2 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$380.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |